// App-Quantinova.ai

58 : Feasibility of a National Class II Matching Strategy for Pediatric Kidney Transplant Candidates

Researchers

Presenter

  • T. Blydt-Hansen

Principal Investigators

  • W. Klement

  • K. Tinckam

  • J. Gill

Medical Centers

  • Canadian Blood Services, Ottawa, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Major histocompatibility complex, class II, DR beta 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved